KNOWLEDGE VAULT
The information you will find on this page provide you with a closer look into our progress on identifying, prioritizing, designing and facilitating the implementation of solutions that drive efficient, effective and high-quality delivery of new medicines.
This video highlights TransCelerate's CQMS conceptual framework, which will provide a holistic clinical quality management system, in turn saving time, increasing efficiencies, and ultimately providing a safer experience for patients.
What is a Clinical Quality Management System (CQMS)?
In this video, we highlight the capabilities and benefits of the Study Workspace that helps manage study site information, documentation and open tasks – greatly improving the site-sponsor relationship.
Study Management Made Simple with SIP
Hear from SIP creators and users about the benefits of the platform and how the SIP transforms communication (engagement) between sites and sponsors when planning and executing clinical trials.
The Shared Investigator Platform (SIP): From Concept to Reality
TransCelerate BioPharma Inc. has designed an example of an electronic label, or eLabel, for interaction with Health Authorities to show the “art of the possible.”
The Art of the Possible
Find out what an eLabel is and how the TransCelerate eLabels Initiative will help advance the journey to a digitally-supported, patient-centric clinical supply chain.
What is an eLabel?
This video describes the purpose of the Clinical Trial Registry of the Future concept and the principles of its design.
What is the Clinical Trial Registry of the Future?
See All Videos
Media
TransCelerate BioPharma Inc. is featured in PM360’s third annual Innovations in Pharma Marketing special issue as an innovative company in 2014. The article entitled “Innovators 2014: Companies” highlights how important innovation is to the success of the life science industry. The article provides a brief overview of TransCelerate and key accomplishments from the original five initiatives: Site Qualification & Training, Risk-Based Monitoring, Clinical Data Standards, Comparator Drug Network and Shared Investigator Platform.
LEARN MORE >
This article reviews TransCelerate’s five key projects in its first year of operation. It also provides a discussion on its future initiatives. TransCelerate now has one of the most prized characteristics of successful organizations: the ability to deliver results on stated initiatives.
LEARN MORE >
This Life Science Leader cover story is a comprehensive overview of TransCelerate Biopharma's founding and vision. The article is an interview with CEO Dalvir Gill, where he discusses the unmet needs TransCelerate is addressing, the power of collaboration among pharmaceutical companies, the organization’s different initiatives and how the key to overcoming skeptics lies in TransCelerate's ability to deliver results.
LEARN MORE >
Initiative Assets
You can search by Initiative or by Keyword
Follow Us
Follow Us on Twitter or Join Us on LinkedIn
The Latest
We have a new podcast from our Member Company, Merck & Co., Inc., on the value and implementation of a clinical QMS.
TransCelerate implores representatives for regulatory authorities to work with industry sponsors, in the spirit of ICH, to identify potential ways to re-harmonize global pharmacovigilance processes and requirements. Read it here.
In a recently published article, the Patient Technology Initiative describes the potential for patient-facing digital technologies to serve a variety of functions in clinical trials.
The eLabels Initiative recently launched a new Design & Delivery Toolkit, as well as other educational materials. Check out the assets page to access this helpful information.
We have a new podcast from our Member Company, Merck & Co., Inc., on the value and implementation of a clinical QMS.
TransCelerate implores representatives for regulatory authorities to work with industry sponsors, in the spirit of ICH, to identify potential ways to re-harmonize global pharmacovigilance processes and requirements. Read it here.
In a recently published article, the Patient Technology Initiative describes the potential for patient-facing digital technologies to serve a variety of functions in clinical trials.
The eLabels Initiative recently launched a new Design & Delivery Toolkit, as well as other educational materials. Check out the assets page to access this helpful information.
Get updates from TransCelerate
